Literature DB >> 129304

Adaptations of the left ventricle to chronic pressure overload.

S Sasayama, J Ross, D Franklin, C M Bloor, S Bishop, R B Dilley.   

Abstract

Left ventricular (LV) function during the adaptation to chronic pressure overload produced by an ascending aortic constriction was analyzed in conscious dogs, instrumented with intraventricular micromanometers and pairs of ultrasonic crystals for measurement of LV wall thickness (WTh) and internal LV chamber diameter. During inflation of the cuff to produce LV pressures averaging 220 mg Hg, calculated peak wall stress (WSt) increased by 55% above control while percent shortening decreased by 24% and mean circumferential shortening velocity (VCF) decreased by 39% from control. By 9 days (mean) after aortic constriction, the cross-sectional area (CSA) of the LV wall increased by 10% and peak WSt fell to 37% above control. End-diastolic diameter (EDD) increased to 4% above control, while percent shortening and mean VCF remained reduced at -12% and -20% of control, respectively. During the phase of concentric hypertrophy (mean 2 1/2 weeks), CSA increased further to 15% above control and WSt fell to 22% above control, while EDD and percent shortening returned to control and mean VCF increased to -7% of control (not significant). At 24 hours after release of the cuff WSt, percent shortening, mean VCF, and peak velocity of LV pressure rise (peak dP/dt) were not significantly different from control. Rapid, partial regression of hypertrophy was observed in some dogs. Thus, the left ventricle responds to chronically elevated pressure by initial dilation with increased WSt followed by gradual wall thickening and consequent reduction of WSt to near normal. After successful adaptation to the pressure overload, hypertrophy per se did not produce intrinsic depression of the myocardial inotropic state.

Entities:  

Mesh:

Year:  1976        PMID: 129304     DOI: 10.1161/01.res.38.3.172

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

1.  Management of patients with aortic valve disease.

Authors:  H T Dodge
Journal:  West J Med       Date:  1977-06

2.  Coexisting cardiac diseases and pressure recovery phenomenon contribute to discrepancy between the echocardiographic severity of aortic stenosis and left ventricular hypertrophy.

Authors:  Ayumu Abe; Taisei Mikami; Sanae Kaga; Kanako Tsuji; Kazunori Okada; Shinobu Yokoyama; Hisao Nishino; Masahiro Nakabachi; Mutsumi Nishida; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  J Echocardiogr       Date:  2013-01-09

3.  Surgical considerations in aortic valve disease.

Authors:  P O Daily
Journal:  West J Med       Date:  1977-06

4.  Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.

Authors:  Sammy Elmariah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

Review 5.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

Review 6.  Assessment and management of aortic valve disease in patients with left ventricular dysfunction.

Authors:  Mackram F Eleid; Sunil Mankad; Paul Sorajja
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

Review 7.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

8.  Detection of clinically significant coronary artery disease in hypertensive patients. Echocardiographic study.

Authors:  J R Dawson; G C Sutton
Journal:  Br Heart J       Date:  1981-12

9.  Predicting the Time Course of Ventricular Dilation and Thickening Using a Rapid Compartmental Model.

Authors:  Colleen M Witzenburg; Jeffrey W Holmes
Journal:  J Cardiovasc Transl Res       Date:  2018-03-17       Impact factor: 4.132

10.  Control of cardiac output in thyrotoxic calves. Evaluation of changes in the systemic circulation.

Authors:  S Goldman; M Olajos; E Morkin
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.